689 related articles for article (PubMed ID: 33658058)
1. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
2. Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark.
Pinna NK; Anjana RM; Saxena S; Dutta A; Gnanaprakash V; Rameshkumar G; Aswath S; Raghavan S; Rani CSS; Radha V; Balasubramanyam M; Pant A; Nielsen T; Jørgensen T; Færch K; Kashani A; Silva MCA; Vestergaard H; Hansen TH; Hansen T; Arumugam M; Nair GB; Das B; Pedersen O; Mohan V; Mande SS
Genome Med; 2021 Mar; 13(1):36. PubMed ID: 33658065
[TBL] [Abstract][Full Text] [Related]
3. Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area.
Balvers M; Deschasaux M; van den Born BJ; Zwinderman K; Nieuwdorp M; Levin E
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579166
[TBL] [Abstract][Full Text] [Related]
4. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
5. Aberrant intestinal microbiota in individuals with prediabetes.
Allin KH; Tremaroli V; Caesar R; Jensen BAH; Damgaard MTF; Bahl MI; Licht TR; Hansen TH; Nielsen T; Dantoft TM; Linneberg A; Jørgensen T; Vestergaard H; Kristiansen K; Franks PW; ; Hansen T; Bäckhed F; Pedersen O
Diabetologia; 2018 Apr; 61(4):810-820. PubMed ID: 29379988
[TBL] [Abstract][Full Text] [Related]
6. Effects of the Lipid Profile, Type 2 Diabetes and Medication on the Metabolic Syndrome-Associated Gut Microbiome.
Gradisteanu Pircalabioru G; Liaw J; Gundogdu O; Corcionivoschi N; Ilie I; Oprea L; Musat M; Chifiriuc MC
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886861
[TBL] [Abstract][Full Text] [Related]
7. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
8. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome.
He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X
Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952
[TBL] [Abstract][Full Text] [Related]
9. Protein Intake, Metabolic Status and the Gut Microbiota in Different Ethnicities: Results from Two Independent Cohorts.
Bel Lassen P; Attaye I; Adriouch S; Nicolaou M; Aron-Wisnewsky J; Nielsen T; Chakaroun R; Le Chatelier E; Forslund S; Belda E; Bork P; Bäckhed F; Stumvoll M; Pedersen O; Herrema H; Groen AK; Pinto-Sietsma SJ; Zwinderman AH; Nieuwdorp M; Clement K; On Behalf Of Metacardis Consortium
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579043
[TBL] [Abstract][Full Text] [Related]
10. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
11. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients.
Elbere I; Silamikelis I; Dindune II; Kalnina I; Ustinova M; Zaharenko L; Silamikele L; Rovite V; Gudra D; Konrade I; Sokolovska J; Pirags V; Klovins J
PLoS One; 2020; 15(10):e0241338. PubMed ID: 33125401
[TBL] [Abstract][Full Text] [Related]
12. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota analyses of Saudi populations for type 2 diabetes-related phenotypes reveals significant association.
Al-Muhanna FA; Dowdell AK; Al Eleq AH; Albaker WI; Brooks AW; Al-Sultan AI; Al-Rubaish AM; Alkharsah KR; Sulaiman RM; Al-Quorain AA; Cyrus C; Alali RA; Vatte C; Robinson FL; Zhou X; Snyder MP; Almuhanna AF; Keating BJ; Piening BD; Al-Ali AK
BMC Microbiol; 2022 Dec; 22(1):301. PubMed ID: 36510121
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method.
Petakh P; Kobyliak N; Kamyshnyi A
Front Cell Infect Microbiol; 2023; 13():1142578. PubMed ID: 36844398
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.
Elbere I; Orlovskis Z; Ansone L; Silamikelis I; Jagare L; Birzniece L; Megnis K; Leskovskis K; Vaska A; Turks M; Klavins K; Pirags V; Briviba M; Klovins J
Gut Microbes; 2024; 16(1):2361491. PubMed ID: 38868903
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus.
Ren Y; Hao L; Liu J; Wang P; Ding Q; Chen C; Song Y
mSystems; 2023 Apr; 8(2):e0114622. PubMed ID: 36853013
[TBL] [Abstract][Full Text] [Related]
18. Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.
Mardinoglu A; Boren J; Smith U
Cell Metab; 2016 Jan; 23(1):10-2. PubMed ID: 26771114
[TBL] [Abstract][Full Text] [Related]
19. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
Maskarinec G; Raquinio P; Kristal BS; Setiawan VW; Wilkens LR; Franke AA; Lim U; Le Marchand L; Randolph TW; Lampe JW; Hullar MAJ
PLoS One; 2021; 16(6):e0250855. PubMed ID: 34161346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
